When a bone fractures, the road to recovery can be long and complex. From immobilization to physical therapy, medical advancements have aimed to speed up and optimize fracture healing. In recent years, photobiomodulation therapy (PBMT) – also known as low-level laser therapy or low-level light therapy – has emerged as a promising candidate in this field. But does it live up to the hype? A comprehensive systematic review and meta-analysis published in Lasers Med Sci (DOI: 10.1007/s10103-025-04376-0) delves into animal studies to answer this critical question. Let’s break down the key findings and what they mean for the future of orthopedic care.

What Is Photobiomodulation Therapy (PBMT)?

First, let’s clarify what PBMT entails. This non-invasive therapy uses low-power lasers or light-emitting diodes (LEDs) to deliver specific wavelengths of light to target tissues. Unlike high-power lasers used for cutting or ablation, PBMT works by stimulating cellular processes – think of it as a “cellular boost” rather than a destructive force. The light penetrates the skin and soft tissues, interacting with mitochondria (the powerhouse of cells) to enhance energy production, reduce inflammation, and promote tissue repair. For fractures, the theory is that PBMT could accelerate bone regeneration, reduce healing time, and improve the strength of the healed bone.

The Study: A Deep Dive Into Animal Research

The research team, led by Parham Hazrati and colleagues from institutions including the University of Michigan School of Dentistry and Tehran University of Medical Sciences, set out to conduct a rigorous analysis of existing animal studies on PBMT and fracture healing. Here’s how they structured their investigation:

Methodology: Following the Gold Standard

Adhering to PRISMA guidelines (a set of principles for transparent and comprehensive systematic reviews), the researchers searched four major databases – PubMed/MEDLINE, Scopus, Embase, and Web of Science – without any date or language restrictions. They focused on animal studies that evaluated PBMT’s effect on complete fractures, excluding incomplete or pathological fractures.

To ensure quality, the team used SYRCLE’s risk of bias assessment tool – a specialized framework for evaluating animal research – to appraise each study. Meta-analysis and sensitivity analysis were then performed using Stata version 16, with a significance level set at 0.05. The study protocol was registered on PROSPERO (ID: CRD42024514398), adding an extra layer of transparency.

Key Details From the Included Studies

After sifting through 1,656 initial studies, only 27 met the strict eligibility criteria. Here’s a snapshot of the data pool:

• Animals Used: Rabbits were the most common subjects (17 studies), followed by rats (10 studies). These species are frequently used in orthopedic research due to their bone structure and healing patterns, which are somewhat analogous to humans.
• Fracture Sites: The tibia (shinbone) was the most targeted site, followed by the femur (thighbone), mandible (jawbone), and radius (forearm bone) – all weight-bearing or functionally critical bones.
• PBMT Parameters: The most commonly used wavelength was 780 nm (laser), followed by 808 nm and 830 nm. LEDs were used in four studies: three as a comparison to lasers and one as the sole therapy. The typical energy density was 4 J/cm², and the power density was 100 mW/cm² – these are standard parameters for PBMT in bone healing research.
• Assessment Methods: Studies used a range of techniques to measure healing, including radiography (X-rays) to visualize bone formation, histology to examine tissue structure at the cellular level, mechanical testing to assess bone strength, and spectroscopy (like Raman spectroscopy) to analyze mineralization.

The Findings: Promising Signals but Mixed Results

The results of the review and meta-analysis paint a nuanced picture:

Positive Trends in Individual Studies

Most of the 27 included studies reported a positive effect of PBMT on fracture healing. For example, some studies observed increased bone formation on radiographs, improved histological scores (indicating better tissue organization), and faster closure of the fracture gap. These individual findings align with the theoretical benefits of PBMT – reducing inflammation, enhancing blood flow, and stimulating osteoblasts (cells that build bone).

Meta-Analysis: No Significant Impact on Key Outcomes

However, when the data was pooled for meta-analysis, the results were less conclusive. The researchers found no significant effect of PBMT on two critical measures:

1. Maximum Fracture Force: This is a key indicator of bone strength – if PBMT were effective, the healed bone should withstand more force before re-fracturing. But the meta-analysis showed no statistically significant difference between PBMT-treated groups and control groups (P > 0.05).
2. Raman Peaks of Hydroxyapatite: Hydroxyapatite is the main mineral component of bone, and its Raman peaks reflect the degree of mineralization (how “hard” and dense the bone is). Again, PBMT had no significant impact on this measure, suggesting it doesn’t enhance bone mineralization.

What Does This Mean for Fracture Healing?

The discrepancy between individual study results and the meta-analysis is noteworthy. Why did most single studies report benefits, but the combined data show no significant effect? There are several possible explanations:

• Variability in Study Design: Different studies used different PBMT parameters (wavelengths, energy densities, treatment timelines), animal species, and fracture models. This variability can make it hard to draw consistent conclusions when pooling data.
• Small Sample Sizes: Many individual studies may have had small sample sizes, which can lead to overestimated effects (statistical “noise” rather than true therapeutic benefit).
• Risk of Bias: Even with SYRCLE’s assessment, some studies may have had inherent biases (e.g., lack of blinding, inconsistent control groups) that inflated their results.

Importantly, this study focuses on animal models – results in animals don’t always translate directly to humans. Bone healing in humans is more complex, with factors like age, nutrition, comorbidities (e.g., diabetes), and lifestyle (e.g., smoking) playing significant roles. So, while PBMT didn’t show significant effects on key outcomes in animal studies, it’s too early to rule it out for human use.

The Future of PBMT in Orthopedics

Despite the mixed results, PBMT remains a promising area of research. Here’s what could come next:

• Standardization of Parameters: To reduce variability, future studies should use consistent PBMT parameters (wavelength, energy density, treatment frequency) based on the most promising data from animal studies.
• Human Clinical Trials: Well-designed, large-scale human trials are needed to determine if PBMT has a meaningful impact on fracture healing in humans. These trials should focus on high-risk fractures (e.g., non-unions, delayed unions) where current treatments are limited.
• Combination Therapies: PBMT may work better when combined with other treatments, such as bone grafts, growth factors, or physical therapy. Future research could explore synergistic effects.
• Targeted Delivery: Advances in technology could allow for more precise delivery of PBMT to the fracture site, ensuring maximum exposure to the healing bone while minimizing exposure to surrounding tissues.

Conclusion

Photobiomodulation therapy shows potential as a non-invasive tool for enhancing fracture healing, with most individual animal studies reporting positive effects. However, the meta-analysis from Hazrati et al. highlights that these benefits may not translate to significant improvements in bone strength or mineralization – two critical markers of successful healing.

As with any emerging therapy, caution is warranted. PBMT is not yet a proven standard of care for fracture healing, but it’s far from a dead end. With more standardized research and human clinical trials, we may soon uncover the true potential of this therapy. For now, patients and clinicians should rely on established fracture healing protocols, but keep an eye on PBMT as a possible adjunctive treatment in the future.

If you’re interested in learning more, you can access the full study here: https://pubmed.ncbi.nlm.nih.gov/40016554/

Stay tuned for updates as research in this field continues to evolve – the next breakthrough in fracture healing could be just a light therapy session away.